On Wednesday 4 June, the Permanent Representatives Committee (Coreper) approved the EU Council’s position on the reform of legislation on medicines.
A negotiating mandate was approved by a large qualified majority, with a view to opening discussions with the European Parliament, which for its part adopted its position in April 2024 (see EUROPE B13652A2).
Data protection. Under the EU Council’s mandate, companies developing innovative medicines will be able to prevent their...